middle.news
Radiopharm unlocks $8 million early to fund clinical development
3:53pm on Monday 26th of October, 2026 AEDT
•
Biotechnology and Pharmaceuticals
Read Story
Radiopharm unlocks $8 million early to fund clinical development
3:53pm on Monday 26th of October, 2026 AEDT
Key Points
$8 million advance from Rockford Capital
Secured against anticipated FY26 R&D tax incentive
Funds allocated to clinical trials and working capital
Commercial interest rate not disclosed
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Radiopharm Theranostics (ASX:RAD)
OPEN ARTICLE